🔗 Share this article

A shadow market for unlicensed slimming medications is being driven by TikTok fitness influencers and sellers on communication apps, based on new investigations.

Experimental Drug Acquiring Traction Via Social Media

Retatrutide, which remains in clinical trials, is being promoted by online personalities for its alleged fat-burning properties. Viewers are encouraged to message these accounts privately for supplier links, while also receiving discount codes.

Thriving Commerce on Messaging Platforms

Additionally, a robust market exists on Telegram, where communities with thousands of participants share comparison photos, injection guides and claims of next-day British shipping. Sellers market the drug there before redirecting customers to WhatsApp for transactions.

Learning About The Experimental Drug

Retatrutide is an experimental injectable created by American pharmaceutical company Eli Lilly. The drug affects three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could help patients reduce up to a quarter of their total weight. Referred to as the “triple G”, the drug is being hailed digitally as the successor to Ozempic.

Medical Professionals Voice Concerns

However, doctors and pharmacists have cautions that the distribution of what is still an unlicensed drug in the United Kingdom is worrisome and could lead to individuals injecting substances of uncertain source.

Some experts said the popularity for the experimental drug could be connected to the rising price of approved weight loss products such as Mounjaro.

Regulatory Position and Implementation

Selling the unapproved drug on TikTok or Telegram is prohibited in the United Kingdom, as it is an unlicensed medication that must not be marketed or supplied for personal consumption under the Human Medicines Regulations 2012.

Several content creators attempt to sidestep the regulations by calling to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and supply can still violate pharmaceutical, advertising, and consumer laws, risking penalties, prosecution or imprisonment.

Service Reaction and Content Elimination

According to TikTok, the service has taken down violative material and banned associated keywords and query recommendations. The company said it was committed to maintaining the service safe and investing in enhancing compliance measures.

Online Trading Operations

Investigations also discovered groups with up to nine thousand participants marketing retatrutide using Telegram's integrated discovery tool, which operates like a online catalog. Entering “retatrutide” immediately brings up groups with numerous of users, filled with photos of weight loss, positive testimonials and detailed instructions for mixing or administering at home.

Within moments of joining one community, a seller posted WhatsApp details, where most purchases take place. The seller provided an guidebook and guaranteed shipping within two days. When questioned whether the substance was authentic, one vendor said: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. Not one inquired about body mass, medical conditions or previous experience.

Product Details and Costs

Inside these groups, messages show black plastic parcels with Royal Mail labels, stating to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, mixed at home with purified liquid, or pre-filled injectors usually priced at 160 pounds for 20mg. When questioned how long a injector should be used, sellers give conflicting answers ranging from a few weeks to “depends on your body”.

Service Moderation and Safety Measures

A spokesperson for the messaging service said it regularly moderated dangerous material on its platform including material that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Cautions

“People are administering materials they cannot confirm. Even if the research behind retatrutide is valid, these digital products may not include what they advertise,” said a pharmacy expert, the director of pharmacy at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor connected the surge in demand to recent price rises for approved weight-loss drugs such as Mounjaro. “With prices increasing, patients are using social media. But counterfeit treatments are extremely dangerous. You can’t be certain what’s contained or whether the conditions they were produced in was clean,” she said.

Her staff has previously encountered individuals injured by self-injection from unverified sources. “We understand the disappointment, but buying from messaging apps or WhatsApp is gambling with your health,” said the doctor. “These substances could be impure or incorrectly dosed.”

Producer Statement

A representative from the pharmaceutical company stated the substance was in phase 3 research studies and had not been evaluated or approved by any regulatory agency globally. “Consequently at this time no one can sell [it] for human use,” they said, noting that any product “falsely representing itself as a Lilly investigational substance not yet approved … may expose patients to potentially serious health risks”.